KRO
Kronos Worldwide, Inc.
NYSE · Basic Materials · Chemicals - Specialty · US
$8.43
−0.24%Year over year
Reported trailing growth
- Revenue
- +2.7%
- EBITDA
- -95.5%
- EBIT
- —
- EPS
- —
- Free cash flow
- +239.6%
- Operating cash flow
- +2239.0%
Forward estimates
Based on analyst estimates
- Revenue
- +7.4%
- EBITDA
- +1872.7%
- EPS
- +165.7%
Three-year CAGR
- Revenue
- -1.2%
- EBITDA
- -53.8%
- EBIT
- —
- Net income
- —
- EPS
- —
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026